Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.

The global Molecular Diagnostics and NAT market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.

This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics and NAT, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics and NAT.

Report Scope

The Molecular Diagnostics and NAT market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostics and NAT market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Molecular Diagnostics and NAT companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Molecular Diagnostics and NAT Market Report

Report Metric	Details
Report Name	Molecular Diagnostics and NAT Market
Segment by Type	Amplification Technologies Amplified Gene Detection Technologies DNA And Oligonucleotide Microarrays Gene Sequencing
Segment by Application	Hospitals and Clinics Research Institutes Diagnostic Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark, Siemens Healthcare, AutoGenomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics and NAT companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Molecular Diagnostics and NAT Market report?

Ans: The main players in the Molecular Diagnostics and NAT Market are Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark, Siemens Healthcare, AutoGenomics

What are the Application segmentation covered in the Molecular Diagnostics and NAT Market report?

Ans: The Applications covered in the Molecular Diagnostics and NAT Market report are Hospitals and Clinics, Research Institutes, Diagnostic Centers

What are the Type segmentation covered in the Molecular Diagnostics and NAT Market report?

Ans: The Types covered in the Molecular Diagnostics and NAT Market report are Amplification Technologies, Amplified Gene Detection Technologies, DNA And Oligonucleotide Microarrays, Gene Sequencing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Amplification Technologies

1.2.3 Amplified Gene Detection Technologies

1.2.4 DNA And Oligonucleotide Microarrays

1.2.5 Gene Sequencing

1.3 Market by Application

1.3.1 Global Molecular Diagnostics and NAT Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals and Clinics

1.3.3 Research Institutes

1.3.4 Diagnostic Centers

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Diagnostics and NAT Market Perspective (2019-2030)

2.2 Molecular Diagnostics and NAT Growth Trends by Region

2.2.1 Global Molecular Diagnostics and NAT Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Molecular Diagnostics and NAT Historic Market Size by Region (2019-2024)

2.2.3 Molecular Diagnostics and NAT Forecasted Market Size by Region (2025-2030)

2.3 Molecular Diagnostics and NAT Market Dynamics

2.3.1 Molecular Diagnostics and NAT Industry Trends

2.3.2 Molecular Diagnostics and NAT Market Drivers

2.3.3 Molecular Diagnostics and NAT Market Challenges

2.3.4 Molecular Diagnostics and NAT Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Diagnostics and NAT Players by Revenue

3.1.1 Global Top Molecular Diagnostics and NAT Players by Revenue (2019-2024)

3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Players (2019-2024)

3.2 Global Molecular Diagnostics and NAT Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Molecular Diagnostics and NAT Revenue

3.4 Global Molecular Diagnostics and NAT Market Concentration Ratio

3.4.1 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics and NAT Revenue in 2023

3.5 Molecular Diagnostics and NAT Key Players Head office and Area Served

3.6 Key Players Molecular Diagnostics and NAT Product Solution and Service

3.7 Date of Enter into Molecular Diagnostics and NAT Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnostics and NAT Breakdown Data by Type

4.1 Global Molecular Diagnostics and NAT Historic Market Size by Type (2019-2024)

4.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2025-2030)

5 Molecular Diagnostics and NAT Breakdown Data by Application

5.1 Global Molecular Diagnostics and NAT Historic Market Size by Application (2019-2024)

5.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Molecular Diagnostics and NAT Market Size (2019-2030)

6.2 North America Molecular Diagnostics and NAT Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Molecular Diagnostics and NAT Market Size by Country (2019-2024)

6.4 North America Molecular Diagnostics and NAT Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Molecular Diagnostics and NAT Market Size (2019-2030)

7.2 Europe Molecular Diagnostics and NAT Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Molecular Diagnostics and NAT Market Size by Country (2019-2024)

7.4 Europe Molecular Diagnostics and NAT Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Molecular Diagnostics and NAT Market Size (2019-2030)

8.2 Asia-Pacific Molecular Diagnostics and NAT Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2019-2024)

8.4 Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Molecular Diagnostics and NAT Market Size (2019-2030)

9.2 Latin America Molecular Diagnostics and NAT Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Molecular Diagnostics and NAT Market Size by Country (2019-2024)

9.4 Latin America Molecular Diagnostics and NAT Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Diagnostics and NAT Market Size (2019-2030)

10.2 Middle East & Africa Molecular Diagnostics and NAT Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2019-2024)

10.4 Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Molecular Diagnostics and NAT Introduction

11.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott Molecular Diagnostics and NAT Introduction

11.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.2.5 Abbott Recent Development

11.3 BD

11.3.1 BD Company Detail

11.3.2 BD Business Overview

11.3.3 BD Molecular Diagnostics and NAT Introduction

11.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.3.5 BD Recent Development

11.4 Biomerieux

11.4.1 Biomerieux Company Detail

11.4.2 Biomerieux Business Overview

11.4.3 Biomerieux Molecular Diagnostics and NAT Introduction

11.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.4.5 Biomerieux Recent Development

11.5 Qiagen

11.5.1 Qiagen Company Detail

11.5.2 Qiagen Business Overview

11.5.3 Qiagen Molecular Diagnostics and NAT Introduction

11.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.5.5 Qiagen Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Detail

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Introduction

11.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Agilent

11.7.1 Agilent Company Detail

11.7.2 Agilent Business Overview

11.7.3 Agilent Molecular Diagnostics and NAT Introduction

11.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.7.5 Agilent Recent Development

11.8 GenMark

11.8.1 GenMark Company Detail

11.8.2 GenMark Business Overview

11.8.3 GenMark Molecular Diagnostics and NAT Introduction

11.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.8.5 GenMark Recent Development

11.9 Siemens Healthcare

11.9.1 Siemens Healthcare Company Detail

11.9.2 Siemens Healthcare Business Overview

11.9.3 Siemens Healthcare Molecular Diagnostics and NAT Introduction

11.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.9.5 Siemens Healthcare Recent Development

11.10 AutoGenomics

11.10.1 AutoGenomics Company Detail

11.10.2 AutoGenomics Business Overview

11.10.3 AutoGenomics Molecular Diagnostics and NAT Introduction

11.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2019-2024)

11.10.5 AutoGenomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Molecular Diagnostics and NAT Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Amplification Technologies

Table 3. Key Players of Amplified Gene Detection Technologies

Table 4. Key Players of DNA And Oligonucleotide Microarrays

Table 5. Key Players of Gene Sequencing

Table 6. Global Molecular Diagnostics and NAT Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Molecular Diagnostics and NAT Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Molecular Diagnostics and NAT Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Molecular Diagnostics and NAT Market Share by Region (2019-2024)

Table 10. Global Molecular Diagnostics and NAT Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Molecular Diagnostics and NAT Market Share by Region (2025-2030)

Table 12. Molecular Diagnostics and NAT Market Trends

Table 13. Molecular Diagnostics and NAT Market Drivers

Table 14. Molecular Diagnostics and NAT Market Challenges

Table 15. Molecular Diagnostics and NAT Market Restraints

Table 16. Global Molecular Diagnostics and NAT Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Molecular Diagnostics and NAT Market Share by Players (2019-2024)

Table 18. Global Top Molecular Diagnostics and NAT Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics and NAT as of 2023)

Table 19. Ranking of Global Top Molecular Diagnostics and NAT Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Molecular Diagnostics and NAT Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Molecular Diagnostics and NAT Product Solution and Service

Table 23. Date of Enter into Molecular Diagnostics and NAT Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Molecular Diagnostics and NAT Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2019-2024)

Table 27. Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2025-2030)

Table 29. Global Molecular Diagnostics and NAT Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Molecular Diagnostics and NAT Revenue Market Share by Application (2019-2024)

Table 31. Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Molecular Diagnostics and NAT Revenue Market Share by Application (2025-2030)

Table 33. North America Molecular Diagnostics and NAT Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Molecular Diagnostics and NAT Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Molecular Diagnostics and NAT Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Molecular Diagnostics and NAT Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Molecular Diagnostics and NAT Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Molecular Diagnostics and NAT Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Molecular Diagnostics and NAT Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Molecular Diagnostics and NAT Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Molecular Diagnostics and NAT Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Molecular Diagnostics and NAT Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Molecular Diagnostics and NAT Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2025-2030) & (US$ Million)

Table 48. Roche Company Detail

Table 49. Roche Business Overview

Table 50. Roche Molecular Diagnostics and NAT Product

Table 51. Roche Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Abbott Company Detail

Table 54. Abbott Business Overview

Table 55. Abbott Molecular Diagnostics and NAT Product

Table 56. Abbott Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 57. Abbott Recent Development

Table 58. BD Company Detail

Table 59. BD Business Overview

Table 60. BD Molecular Diagnostics and NAT Product

Table 61. BD Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 62. BD Recent Development

Table 63. Biomerieux Company Detail

Table 64. Biomerieux Business Overview

Table 65. Biomerieux Molecular Diagnostics and NAT Product

Table 66. Biomerieux Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 67. Biomerieux Recent Development

Table 68. Qiagen Company Detail

Table 69. Qiagen Business Overview

Table 70. Qiagen Molecular Diagnostics and NAT Product

Table 71. Qiagen Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 72. Qiagen Recent Development

Table 73. Thermo Fisher Scientific Company Detail

Table 74. Thermo Fisher Scientific Business Overview

Table 75. Thermo Fisher Scientific Molecular Diagnostics and NAT Product

Table 76. Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 77. Thermo Fisher Scientific Recent Development

Table 78. Agilent Company Detail

Table 79. Agilent Business Overview

Table 80. Agilent Molecular Diagnostics and NAT Product

Table 81. Agilent Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 82. Agilent Recent Development

Table 83. GenMark Company Detail

Table 84. GenMark Business Overview

Table 85. GenMark Molecular Diagnostics and NAT Product

Table 86. GenMark Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 87. GenMark Recent Development

Table 88. Siemens Healthcare Company Detail

Table 89. Siemens Healthcare Business Overview

Table 90. Siemens Healthcare Molecular Diagnostics and NAT Product

Table 91. Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 92. Siemens Healthcare Recent Development

Table 93. AutoGenomics Company Detail

Table 94. AutoGenomics Business Overview

Table 95. AutoGenomics Molecular Diagnostics and NAT Product

Table 96. AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2019-2024) & (US$ Million)

Table 97. AutoGenomics Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Molecular Diagnostics and NAT Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Molecular Diagnostics and NAT Market Share by Type: 2023 VS 2030

Figure 3. Amplification Technologies Features

Figure 4. Amplified Gene Detection Technologies Features

Figure 5. DNA And Oligonucleotide Microarrays Features

Figure 6. Gene Sequencing Features

Figure 7. Global Molecular Diagnostics and NAT Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Molecular Diagnostics and NAT Market Share by Application: 2023 VS 2030

Figure 9. Hospitals and Clinics Case Studies

Figure 10. Research Institutes Case Studies

Figure 11. Diagnostic Centers Case Studies

Figure 12. Molecular Diagnostics and NAT Report Years Considered

Figure 13. Global Molecular Diagnostics and NAT Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Molecular Diagnostics and NAT Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Molecular Diagnostics and NAT Market Share by Region: 2023 VS 2030

Figure 16. Global Molecular Diagnostics and NAT Market Share by Players in 2023

Figure 17. Global Top Molecular Diagnostics and NAT Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics and NAT as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Molecular Diagnostics and NAT Revenue in 2023

Figure 19. North America Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Molecular Diagnostics and NAT Market Share by Country (2019-2030)

Figure 21. United States Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Molecular Diagnostics and NAT Market Share by Country (2019-2030)

Figure 25. Germany Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Molecular Diagnostics and NAT Market Share by Region (2019-2030)

Figure 33. China Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Molecular Diagnostics and NAT Market Share by Country (2019-2030)

Figure 41. Mexico Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Molecular Diagnostics and NAT Market Share by Country (2019-2030)

Figure 45. Turkey Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Molecular Diagnostics and NAT Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 48. Abbott Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 49. BD Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 50. Biomerieux Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 51. Qiagen Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 53. Agilent Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 54. GenMark Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 55. Siemens Healthcare Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 56. AutoGenomics Revenue Growth Rate in Molecular Diagnostics and NAT Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions